Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis

Journal of Dermatological Science

Volumn 75, Issue 3, 2014, Pages 204-207

  Kyoya, Mikiko ^a   Kawakami, Tamihiro ^a   Soma, Yoshinao ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FEXOFENADINE; INTERLEUKIN 31; LACTATE DEHYDROGENASE; OLOPATADINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRYPTASE; ANTIHISTAMINIC AGENT; BIOLOGICAL MARKER; CCL17 PROTEIN, HUMAN; CHEMOKINE; IL31 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; ATOPIC DERMATITIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DRUG RESPONSE; ENZYME BLOOD LEVEL; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LABORATORY DIAGNOSIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS SCORE; SCORAD INDEX; SCORING SYSTEM; TABLET; BLOOD; CHEMISTRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PRURITUS; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; BIOLOGICAL MARKERS; CHEMOKINE CCL17; CHEMOKINES; DERMATITIS, ATOPIC; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; INTERLEUKINS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; PRURITUS; TRYPTASES; YOUNG ADULT;

EID: 84904975158     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.06.001     Document Type: Letter

References (9)

1. Otsuka A., Honda T., Doi H., Miyachi Y., Kabashima K. An H1-histamine receptor antagonist decreases serum interleukin-31 levels in patients with atopic dermatitis. Br J Dermatol 2011, 164:455-456.
2. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980, 92:44-47.
3. European Task Force on Atopic Dermatitis Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993, 186:23-31.
4. Kawakami T., Kaminishi K., Soma Y., Kushimoto T., Mizoguchi M. Oral antihistamine therapy influences plasma tryptase levels in adult atopic dermatitis. J Dermatol Sci 2006, 43:127-134.
5. Morita E., Takahashi H., Niihara H., Dekio I., Sumikawa Y., Murakami Y., et al. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis. Allergy 2010, 65:1166-1172.
6. Kou K., Aihara M., Matsunaga T., Chen H., Taguri M., Morita S., et al. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis. Arch Dermatol Res 2012, 304:305-312.
7. Otsuka A., Honda T., Doi H., Miyachi Y., Kabashima K. An H1-histamine receptor antagonist decreases serum interleukin-31 levels in patients with atopic dermatitis. Br J Dermatol 2011, 164:455-456.
8. Dillon S.R., Sprecher C., Hammond A., Bilsborough J., Rosenfeld-Franklin M., Presnell S.R., et al. Intreleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004, 5:752-760.
9. Neis M.M., Peters B., Dreuw A., Wenzel J., Bieber T., Mauch C., et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006, 118:930-937.